Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/25/2026

1. QCOM
2. CBRS
3. FDX
4. USO
5. MU
6. HTZ
7. SPY
8. KBH
9. HON
10. TTWO

Go back to Theravance Biopharma, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Business Update

Theravance Biopharma (TBPH) Misses Q4 EPS by 4c, Revenues Beat

February 24, 2020 4:14 PM EST

Theravance Biopharma (NASDAQ: TBPH) reported Q4 EPS of ($1.17), $0.04 worse than the analyst estimate of ($1.13). Revenue for the quarter came in at $29.5 million versus the consensus estimate of $16.84 million.

Rick E Winningham, Chairman and Chief Executive Officer, commented: "2019 was a year of achievement for Theravance Biopharma across our business. We successfully launched YUPELRI with Mylan and advanced our... More